A new phase 1 randomized controlled trial finds that a single dose of the ChAdox1 Rift Valley fever (RVF) vaccine appears safe, tolerable, and able to elicit a good immune response in healthy adults in endemic regions of the world.
For the…
Rift Valley fever vaccine safe, immune-producing in adults, early-stage trial shows
